1. Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment.
   Qiang Wang et al, 2021, Toxicol Res (Camb) CrossRef
2. Shikonin Derivatives Inhibit Inflammation Processes and Modulate MAPK Signaling in Human Healthy and Osteoarthritis Chondrocytes
   Birgit Lohberger et al, 2022, IJMS CrossRef
3. Role of Plant-Derived Active Constituents in Cancer Treatment and Their Mechanisms of Action
   Abdul Waheed Khan et al, 2022, Cells CrossRef
4. In vitro characterization and molecular dynamic simulation of shikonin as a tubulin-targeted anticancer agent
   Gudapureddy Radha et al, 2022, Computers in Biology and Medicine CrossRef
5. Shikonin derivatives cause apoptosis and cell cycle arrest in human chondrosarcoma cells via death receptors and MAPK regulation
   Birgit Lohberger et al, 2022, BMC Cancer CrossRef
6. Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy
   Yuting Cui et al, 2022, Front. Pharmacol. CrossRef
7. Nano-constructs targeting the primary cellular energy source of cancer cells for modulating tumor progression
   Krishna Yadav et al, 2022, OpenNano CrossRef
8. Targeting glycolysis in non-small cell lung cancer: Promises and challenges.
   Jia-Qi Xu et al, 2022, Front Pharmacol CrossRef
9. Circular RNA Sec61 subunit alpha isoform 1 by competitive absorption of microRNA ‐513a‐5p mediates peroxisomal biogenesis factor 5 expression and promotes the malignant phenotype of non‐small cell lung cancer
   Zhe‐Ping Duan et al, 2022, The Kaohsiung J of Med Scie CrossRef
10. Natural Plant-Derived Compounds in Food and Cosmetics: A Paradigm of Shikonin and Its Derivatives
    Sonia Malik et al, 2023, Materials CrossRef
11. DDQN-based optimal targeted therapy with reversible inhibitors to combat the Warburg effect
    Jose M. Sanz Nogales et al, 2023, Mathematical Biosciences CrossRef
12. Investigation of the effects of catharanthine and Q10 on Nrf2 and its association with MMP-9, MRP1, and Bcl-2 and apoptosis in a model of hepatocellular carcinoma
    Nafiseh Heidari-Kalvani et al, 2023, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
13. Comparative clinical significance and biological roles of PFKFB family members in oral squamous cell carcinoma
    Kai-Fang Hu et al, 2023, Cancer Cell Int CrossRef
14. Phytochemicals Target Multiple Metabolic Pathways in Cancer
    Oleg Shuvalov et al, 2023, Antioxidants CrossRef
15. Hitting the Sweet Spot: How Glucose Metabolism Is Orchestrated in Space and Time by Phosphofructokinase-1
    Melissa Campos et al, 2023, Cancers CrossRef
16. Triptolide restrains the growth, invasion, stemness, and glycolysis of non‐small cell lung cancer cells by PFKFB2‐mediated PI3K/AKT pathway
    Jiankun Ren et al, 2024, Chem Biol Drug Des CrossRef
17. RNA methylation, metabolic reprogramming and pulmonary hypertension
    Li Hu et al, 2023, Chin. Sci. Bull. CrossRef
18. Bioinformatics Analysis and Verification of Metabolic Abnormalities in Esophageal Squamous Carcinoma
    Duo Tang et al, 2024, CCHTS CrossRef
19. Shikonin Inhibits Oral Cancer Progression Through Suppression of Metastasis and Angiogenesis and Induction of Autophagy and Apoptosis
    Min Huan Wu et al, 2024, Jundishapur J Nat Pharm Prod CrossRef
20. Bioavailability and Pharmacological Properties of Shikonin‐ A Phytocompound from Lithospermum Erythrorhizon
    Stuti Biswal et al, 2024, ChemistrySelect CrossRef
21. Shikonin induces the apoptosis and pyroptosis of EGFR-T790M-mutant drug-resistant non-small cell lung cancer cells via the degradation of cyclooxygenase-2
    Shaoyi Cao et al, 2024, Eur J Med Res CrossRef